Advertisement

Gene Polymorphisms and Signaling Defects

  • Christine MannhalterEmail author
  • Michael Poteser
  • Klaus Groschner
Chapter
  • 637 Downloads

Abstract

Understanding heritability of cardiovascular risk is a key issue in preventive medicine and of particular importance for the development of cost-efficient strategies to preserve cardiovascular health. Recent progress in genotyping technologies enabled detailed insight into human genetic variability. Linkage analysis and genome-wide association screens have complemented candidate gene studies to uncover a large array of genetic variations associated with cardiovascular pathologies. For the majority of identified gene polymorphisms, the clinical impact is as yet unclear and the available information is still of limited value for cardiovascular risk prediction. However, genetic discoveries have greatly improved our understanding of pathophysiological principles. The identification of novel molecular players and target structures contributed significantly to therapeutic progress. In this chapter we aim to present an overview on polymorphisms in genes with proven or at least convincingly suggested causal relation to secondary risk factors and/or cardiovascular phenotypes. Special attention will be paid to functional consequences of genetic variations. Many of the ­polymorphisms that are causally involved in the pathogenesis of cardiovascular dysfunction impair cellular signaling processes and may in turn affect regulatory genetic networks. Unraveling of molecular mechanisms that link genetic variability to pathological phenotypes is still at a rather early stage. We will present here a selection of these mechanisms and discuss their clinical significance.

Keywords

SNPs Hypertension Diabetes Obesity Dyslipidemia Electrical remodeling Hemostatic disorders 

References

  1. Abifadel M, Varret M, Rabès JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derré A, Villéger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C (2003) Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34(2):154–156PubMedCrossRefGoogle Scholar
  2. Akhter Q, Masood A, Ashraf R, Majid S, Rasool S, Khan T, Rashid T, Sameer AS, Ganai BA (2012) Polymorphisms in the 3′UTR of the human leptin gene and their role in hypertension. Mol Med Rep 5(4):1058–1062PubMedGoogle Scholar
  3. Albert MA, Pare G, Morris A, Rose L, Buring J, Ridker PM, Zee RY (2009) Candidate genetic variants in the fibrinogen, methylenetetrahydrofolate reductase, and intercellular adhesion molecule-1 genes and plasma levels of fibrinogen, homocysteine, and intercellular adhesion molecule-1 among various race/ethnic groups: data from the Women’s Genome Health Study. Am Heart J 157(4):777–83.e1PubMedCrossRefGoogle Scholar
  4. Alevriadou BR, Moake JL, Turner NA, Ruggeri ZM, Folie BJ, Phillips MD, Schreiber AB, Hrinda ME, McIntire LV (1993) Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets. Blood 81:1263–1276PubMedGoogle Scholar
  5. Allison DB, Heo M, Faith MS, Pietrobelli A (1998) Meta-analysis of the association of the Trp64Arg polymorphism in the beta3 adrenergic receptor with body mass index. Int J Obes Relat Metab Disord 22(6):559–566PubMedCrossRefGoogle Scholar
  6. Altshuler D, Hirschhorn JN, Klannemark M, Lindgren CM, Vohl MC, Nemesh J, Lane CR, Schaffner SF, Bolk S, Brewer C, Tuomi T, Gaudet D, Hudson TJ, Daly M, Groop L, Lander ES (2000) The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 26(1):76–80PubMedCrossRefGoogle Scholar
  7. Amin AS, Giudicessi JR, Tijsen AJ, Spanjaart AM, Reckman YJ, Klemens CA, Tanck MW, Kapplinger JD, Hofman N, Sinner MF, Müller M, Wijnen WJ, Tan HL, Bezzina CR, Creemers EE, Wilde AA, Ackerman MJ, Pinto YM (2012) Variants in the 3′ untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner. Eur Heart J 33(6):714–723PubMedCrossRefGoogle Scholar
  8. Andersen G, Wegner L, Yanagisawa K, Rose CS, Lin J, Glümer C, Drivsholm T, Borch-Johnsen K, Jørgensen T, Hansen T, Spiegelman BM, Pedersen O (2005) Evidence of an association between genetic variation of the coactivator PGC-1beta and obesity. J Med Genet 42(5):402–407PubMedCrossRefGoogle Scholar
  9. Andreasen CH, Stender-Petersen KL, Mogensen MS, Torekov SS, Wegner L, Andersen G, Nielsen AL, Albrechtsen A, Borch-Johnsen K, Rasmussen SS, Clausen JO, Sandbaek A, Lauritzen T, Hansen L, Jørgensen T, Pedersen O, Hansen T (2008) Low physical activity accentuates the effect of the FTO rs9939609 polymorphism on body fat accumulation. Diabetes 57:95–101PubMedCrossRefGoogle Scholar
  10. Antoni G, Oudot-Mellakh T, Dimitromanolakis A, Germain M, Cohen W, Wells P, Lathrop M, Gagnon F, Morange PE, Tregouet DA (2011) Combined analysis of three genome-wide association studies on vWF and FVIII plasma levels. BMC Med Genet 12:102PubMedCrossRefGoogle Scholar
  11. Arbustini E, Diegoli M, Morbini P, Dal Bello B, Banchieri N, Pilotto A, Magani F, Grasso M, Narula J, Gavazzi A, Viganò M, Tavazzi L (2000) Prevalence and characteristics of dystrophin defects in adult male patients with dilated cardiomyopathy. J Am Coll Cardiol 35(7): 1760–1768PubMedCrossRefGoogle Scholar
  12. Ariens RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ (2000) The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood 96:988–995PubMedGoogle Scholar
  13. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257(1):79–83PubMedCrossRefGoogle Scholar
  14. Arking DE, Pfeufer A, Post W, Kao WH, Newton-Cheh C, Ikeda M, West K, Kashuk C, Akyol M, Perz S, Jalilzadeh S, Illig T, Gieger C, Guo CY, Larson MG, Wichmann HE, Marbán E, O’Donnell CJ, Hirschhorn JN, Kääb S, Spooner PM, Meitinger T, Chakravarti A (2006) A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet 38(6):644–651PubMedCrossRefGoogle Scholar
  15. Ay C, Thom K, Abu-Hamdeh F, Horvath B, Quehenberger P, Male C, Mannhalter C, Pabinger I (2010) Determinants of factor VIII plasma levels in carriers of haemophilia A and in control women. Haemophilia 16(1):111–117PubMedCrossRefGoogle Scholar
  16. Babu MS, Prabha TS, Kaul S, Al-Hazzani A, Shafi G, Roy S, Balakrishna N, Jyothy A, Munshi A (2012) Association of genetic variants of fibrinolytic system with stroke and stroke subtypes. Gene 495(1):76–80PubMedCrossRefGoogle Scholar
  17. Bach J, Endler G, Winkelmann BR, Boehm BO, Maerz W, Mannhalter C, Hellstern P (2008) Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk. J Thromb Haemost 6(2):291–296PubMedGoogle Scholar
  18. Bender N, Allemann N, Marek D, Vollenweider P, Waeber G, Mooser V, Egger M, Bochud M (2011) Association between variants of the leptin receptor gene (LEPR) and overweight: a systematic review and an analysis of the CoLaus study. PLoS One 6(10):e26157PubMedCrossRefGoogle Scholar
  19. Benetti R, Copetti T, Dell’Orso S, Melloni E, Brancolini C, Monte M, Schneider C (2005) The calpain system is involved in the constitutive regulation of beta-catenin signaling functions. J Biol Chem 280(23):22070–22080PubMedCrossRefGoogle Scholar
  20. Benn M, Nordestgaard BG, Grande P, Schnohr P, Tybjaerg-Hansen A (2010) PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses. J Am Coll Cardiol 55(25):2833–2842PubMedCrossRefGoogle Scholar
  21. Benzinou M, Creemers JW, Choquet H, Lobbens S, Dina C, Durand E, Guerardel A, Boutin P, Jouret B, Heude B, Balkau B, Tichet J, Marre M, Potoczna N, Horber F, Le Stunff C, Czernichow S, Sandbaek A, Lauritzen T, Borch-Johnsen K, Andersen G, Kiess W, Körner A, Kovacs P, Jacobson P, Carlsson LM, Walley AJ, Jørgensen T, Hansen T, Pedersen O, Meyre D, Froguel P (2008) Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet 40(8):943–945PubMedCrossRefGoogle Scholar
  22. Bereczky Z, Muszbek L (2011) Factor XIII and venous thromboembolism. Semin Thromb Hemost 37(3):305–314PubMedCrossRefGoogle Scholar
  23. Bernardi F, Marchetti G, Pinotti M, Arcieri P, Baroncini C, Papacchini M, Zepponi E, Ursicino N, Chiarotti F, Mariani G (1996) Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma. Arterioscler Thromb Vasc Biol 16:72–76PubMedGoogle Scholar
  24. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH (1994) Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 369(6475):64–67PubMedCrossRefGoogle Scholar
  25. Bezzina CR, Verkerk AO, Busjahn A, Jeron A, Erdmann J, Koopmann TT, Bhuiyan ZA, Wilders R, Mannens MM, Tan HL, Luft FC, Schunkert H, Wilde AA (2003) A common polymorphism in KCNH2 (HERG) hastens cardiac repolarization. Cardiovasc Res 59(1):27–36PubMedCrossRefGoogle Scholar
  26. Björck HM, Eriksson P, Alehagen U, De Basso R, Ljungberg LU, Persson K, Dahlström U, Länne T (2011) Gender-specific association of the plasminogen activator inhibitor-1 4G/5G polymorphism with central arterial blood pressure. Am J Hypertens 24(7):802–808PubMedCrossRefGoogle Scholar
  27. Blake GJ, Schmitz C, Lindpaintner K, Ridker PM (2001) Mutation in the promoter region of the beta-fibrinogen gene and the risk of future myocardial infarction, stroke and venous thrombosis. Eur Heart J 22:2262–2266PubMedCrossRefGoogle Scholar
  28. Brass LM, Isaacsohn JL, Merikangas KR, Robinette CD (1992) A study of twins and stroke. Stroke 23:221–223PubMedCrossRefGoogle Scholar
  29. Brass LM, Hartigan PM, Page WF, Concato J (1996) Importance of cerebrovascular disease in studies of myocardial infarction. Stroke 27:1173–1176PubMedGoogle Scholar
  30. Bray PF (2000) Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 7(5):284–289PubMedCrossRefGoogle Scholar
  31. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232:34–47PubMedCrossRefGoogle Scholar
  32. Büsst CJ, Bloomer LDS, Scurrah KJ, Ellis JA, Barnes TA, Charchar FJ, Braund P, Hopkins PN, Samani NJ, Hunt SC, Tomaszewski M, Harrap SB (2011) The epithelial sodium channel ­γ-subunit gene and blood pressure: family based association, renal gene expression, and physiological analyses. Hypertension 58:1073–1078PubMedCrossRefGoogle Scholar
  33. Calafell F, Almasy L, Sabater-Lleal M, Buil A, Mordillo C, Ramírez-Soriano A, Sikora M, Souto JC, Blangero J, Fontcuberta J, Soria JM (2010) Sequence variation and genetic evolution at the human F12 locus: mapping quantitative trait nucleotides that influence FXII plasma levels. Hum Mol Genet 19(3):517–525PubMedCrossRefGoogle Scholar
  34. Campo G, Valgimigli M, Ferraresi P, Malagutti P, Baroni M, Arcozzi C, Gemmati D, Percoco G, Parrinello G, Ferrari R, Bernardi F (2006) Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events. Arterioscler Thromb Vasc Biol 26(12):2800–2806PubMedCrossRefGoogle Scholar
  35. Cappola TP, Li M, He J, Ky B, Gilmore J, Qu L, Keating B, Reilly M, Kim CE, Glessner J, Frackelton E, Hakonarson H, Syed F, Hindes A, Matkovich SJ, Cresci S, Dorn GW (2010) Common variants in HSPB7 and FRMD4B associated with advanced heart failure. Circ Cardiovasc Genet 3(2):147–154PubMedCrossRefGoogle Scholar
  36. Carter AM, Catto AJ, Grant PJ (1998) Determinants of tPA antigen and associations with coronary artery disease and acute cerebrovascular disease. Thromb Haemost 80(4):632–636PubMedGoogle Scholar
  37. Carter AM, Catto AJ, Grant PJ (1999) Association of the alpha-fibrinogen Thr312Ala polymorphism with poststroke mortality in subjects with atrial fibrillation. Circulation 99:2423–2426PubMedCrossRefGoogle Scholar
  38. Carty CL, Heagerty P, Heckbert SR, Jarvik GP, Lange LA, Cushman M, Tracy RP, Reiner AP (2010) Interaction between fibrinogen and IL-6 genetic variants and associations with cardiovascular disease risk in the Cardiovascular Health Study. Ann Hum Genet 74(1):1–10PubMedCrossRefGoogle Scholar
  39. Ceelie H, Spaargaren-van Riel CC, Bertina RM, Vos HL (2004) G20210A is a functional mutation in the prothrombin gene; effect on protein levels and 3’-end formation. J Thromb Haemost 2(1):119–127PubMedCrossRefGoogle Scholar
  40. Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris TP, Rastinejad F (2008) Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature 456:350–356PubMedCrossRefGoogle Scholar
  41. Chinchilla A, Daimi H, Lozano-Velasco E, Dominguez JN, Caballero R, Delpon E, Tamargo J, Cinca J, Hove-Madsen L, Aranega AE, Franco D (2011) Pitx2 insufficiency leads to atrial electrical and structural remodeling linked to arrhythmogenesis. Circ Cardiovasc Genet 4:269–279PubMedCrossRefGoogle Scholar
  42. Christoffels VM, Smits GJ, Kispert A, Moorman AF (2010) Development of the pacemaker tissues of the heart. Circ Res 106:240–254PubMedCrossRefGoogle Scholar
  43. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O’Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, Moller DE (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143(3):998–1007PubMedCrossRefGoogle Scholar
  44. Corbo RM, Scacchi R (1999) Apolipoprotein E (APOE) allele distribution in the world. Is APOE∗4 a‘thrifty’ allele? Ann Hum Genet 63(4):301–310PubMedCrossRefGoogle Scholar
  45. Corral J, Gonzalez-Conejero R, Iniesta JA, Rivera J, Martinez C, Vicente V (2000) The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica 85:293–297PubMedGoogle Scholar
  46. Dahlbäck B, Carlsson M, Svensson PJ (1993) Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C. Proc Natl Acad Sci USA 90:1004–1008PubMedCrossRefGoogle Scholar
  47. Davi G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482–2494PubMedCrossRefGoogle Scholar
  48. Debette S, Seshadri S (2009) Genetics of atherothrombotic and lacunar stroke. Circ Cardiovasc Genet 2(2):191–198PubMedCrossRefGoogle Scholar
  49. Dehghan A, Yang Q, Peters A, Basu S, Bis JC, Rudnicka AR, Kavousi M, Chen MH, Baumert J, Lowe GD, McKnight B, Tang W, de Maat M, Larson MG, Eyhermendy S, McArdle WL, Lumley T, Pankow JS, Hofman A, Massaro JM, Rivadeneira F, Kolz M, Taylor KD, van Duijn CM, Kathiresan S, Illig T, Aulchenko YS, Volcik KA, Johnson AD, Uitterlinden AG, Tofler GH, Gieger C; Wellcome Trust Case Control Consortium, Psaty BM, Couper DJ, Boerwinkle E, Koenig W, O’Donnell CJ, Witteman JC, Strachan DP, Smith NL, Folsom AR (2009) Association of novel genetic loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circ Cardiovasc Genet 2(2):125–133Google Scholar
  50. De la Peña-Díaz A, Izaguirre-Avila R, Anglés-Cano E (2000) Lipoprotein Lp(a) and atherothrombotic disease. Arch Med Res 31(4):353–359PubMedCrossRefGoogle Scholar
  51. Delluc A, Gourhant L, Lacut K, Mercier B, Audrezet MP, Nowak E, Oger E, Leroyer C, Mottier D, Le Gal G, Couturaud F (2010) Association of common genetic variations and idiopathic venous thromboembolism. Results from EDITh, a hospital-based case–control study. Thromb Haemost 103(6):1161–1169PubMedCrossRefGoogle Scholar
  52. DeKroon R, Robinette JB, Hjelmeland AB, Wiggins E, Blackwell M, Mihovilovic M, Fujii M, York J, Hart J, Kontos C, Rich J, Strittmatter WJ (2006) APOE4-VLDL inhibits the HDL-activated phosphatidylinositol 3-kinase/Akt pathway via the phosphoinositol phosphatase SHIP2. Circ Res 99:829–836PubMedCrossRefGoogle Scholar
  53. Diness JG, Sorensen US, Nissen JD, Al-Shahib B, Jespersen T, Grunnet M, Hansen RS (2010) Inhibition of small-conductance Ca2  +  −activated K  +  channels terminates and protects against atrial fibrillation. Circ Arrhythm Electrophysiol 3:380–390PubMedCrossRefGoogle Scholar
  54. Eisenach JH, Wittwer ED (2010) {beta}-Adrenoceptor gene variation and intermediate physiological traits: prediction of distant phenotype. Exp Physiol 95(7):757–764PubMedCrossRefGoogle Scholar
  55. Ellinor PT, Lunetta KL, Albert CM, Glazer NL, Ritchie MD, Smith AV, Arking DE, Müller-Nurasyid M, Krijthe BP, Lubitz SA, Bis JC, Chung MK, Dörr M, Ozaki K, Roberts JD, Smith JG, Pfeufer A, Sinner MF, Lohman K, Ding J, Smith NL, Smith JD, Rienstra M, Rice KM, Van Wagoner DR, Magnani JW, Wakili R, Clauss S, Rotter JI, Steinbeck G, Launer LJ, Davies RW, Borkovich M, Harris TB, Lin H, Völker U, Völzke H, Milan DJ, Hofman A, Boerwinkle E, Chen LY, Soliman EZ, Voight BF, Li G, Chakravarti A, Kubo M, Tedrow UB, Rose LM, Ridker PM, Conen D, Tsunoda T, Furukawa T, Sotoodehnia N, Xu S, Kamatani N, Levy D, Nakamura Y, Parvez B, Mahida S, Furie KL, Rosand J, Muhammad R, Psaty BM, Meitinger T, Perz S, Wichmann HE, Witteman JC, Kao WH, Kathiresan S, Roden DM, Uitterlinden AG, Rivadeneira F, McKnight B, Sjögren M, Newman AB, Liu Y, Gollob MH, Melander O, Tanaka T, Stricker BH, Felix SB, Alonso A, Darbar D, Barnard J, Chasman DI, Heckbert SR, Benjamin EJ, Gudnason V, Kääb S (2012) Meta-analysis identifies six new susceptibility loci for atrial fibrillation. Nat Genet 44(6):670–675PubMedCrossRefGoogle Scholar
  56. Endler G, Mannhalter C (2003) Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta 330:31–55PubMedCrossRefGoogle Scholar
  57. Endler G, Lalouschek W, Exner M, Mitterbauer G, Häring D, Mannhalter C (2000) The 4G/4G genotype at nucleotide position −675 in the promoter region of the plasminogen activator inhibitor 1 (PAI-1) gene is less frequent in young patients with minor stroke than in controls. Br J Haematol 110(2):469–471PubMedCrossRefGoogle Scholar
  58. Endler G, Mannhalter C, Sunder-Plassmann H, Lalouschek W, Kapiotis S, Exner M, Jordanova N, Meier S, Kunze F, Wagner O, Huber K (2001) Homozygosity for the C>T polymorphism at nucleotide 46 in the 5′untranslated region of the factor XII gene protects from development of acute coronary syndrome. Br J Haematol 115:1007–1009PubMedCrossRefGoogle Scholar
  59. Endler G, Funk M, Haering D, Lalouschek W, Lang W, Mirafzal M, Wagner O, Mannhalter C (2003) Is the factor XIII 34Val/Leu polymorphism a protective factor for cerebrovascular disease? Br J Haematol 120(2):310–314PubMedCrossRefGoogle Scholar
  60. Endler G, Marsik C, Jilma B, Schickbauer T, Quehenberger P, Mannhalter C (2007) Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 5(6):1143–1148PubMedCrossRefGoogle Scholar
  61. Erdmann J, Grosshennig A, Braund PS, König IR, Hengstenberg C, Hall AS, Linsel-Nitschke P, Kathiresan S, Wright B, Trégouët DA, Cambien F, Bruse P, Aherrahrou Z, Wagner AK, Stark K, Schwartz SM, Salomaa V, Elosua R, Melander O, Voight BF, O’Donnell CJ, Peltonen L, Siscovick DS, Altshuler D, Merlini PA, Peyvandi F, Bernardinelli L, Ardissino D, Schillert A, Blankenberg S, Zeller T, Wild P, Schwarz DF, Tiret L, Perret C, Schreiber S, El Mokhtari NE, Schäfer A, März W, Renner W, Bugert P, Klüter H, Schrezenmeir J, Rubin D, Ball SG, Balmforth AJ, Wichmann HE, Meitinger T, Fischer M, Meisinger C, Baumert J, Peters A, Ouwehand WH; Italian Atherosclerosis, Thrombosis, and Vascular Biology Working Group; Myocardial Infarction Genetics Consortium; Wellcome Trust Case Control Consortium; Cardiogenics Consortium, Deloukas P, Thompson JR, Ziegler A, Samani NJ, Schunkert H (2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nat Genet 41(3):280–282Google Scholar
  62. Erikson P, Kallin B, Van’T Hooft FM, Bovenholm P, Hamsten A (1995) Allele-specific increase in basal transcription of plasminogen activator inhibitor 1 gene is associated with myocardial infarction. Proc Natl Acad Sci USA 92:1851–1855CrossRefGoogle Scholar
  63. Evans JC, Frayling TM, Cassell PG, Saker PJ, Hitman GA, Walker M, Levy JC, O’Rahilly S, Rao PV, Bennett AJ, Jones EC, Menzel S, Prestwich P, Simecek N, Wishart M, Dhillon R, Fletcher C, Millward A, Demaine A, Wilkin T, Horikawa Y, Cox NJ, Bell GI, Ellard S, McCarthy MI, Hattersley AT (2001) Studies of association between the gene for calpain-10 and type 2 diabetes mellitus in the United Kingdom. Am J Hum Genet 69:544–552PubMedCrossRefGoogle Scholar
  64. Feng T, Elston RC, Zhu X (2011) Detecting rare and common variants for complex traits: sibpair and odds ratio weighted sum statistics (SPWSS, ORWSS). Genet Epidemiol 35(5):398–409PubMedCrossRefGoogle Scholar
  65. Flanagan SE, Clauin S, Bellanne-Chantelot C, de Lonlay P, Harries LW, Gloyn AL, Ellard S (2009) Update of mutations in the genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism. Hum Mutat 30:170–180PubMedCrossRefGoogle Scholar
  66. Folsom AR, Rosamond WD, Shahar E, Cooper LS, Aleksic N, Nieto FJ, Rasmussen ML, Wu KK (1999) Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study Investigators. Circulation 100:736–742PubMedCrossRefGoogle Scholar
  67. Forte GI, Vaccarino L, Palmeri M, Branzi A, Caldarera CM, Scola L, Caruso C, Licastro F, Lio D (2011) Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction. Biogerontology 12(5):485–490PubMedCrossRefGoogle Scholar
  68. Franco RF, Trip MD, ten Cate H, van den Ende A, Prins MH, Kastelein JJ, Reitsma PH (1999) The 20210 G  →  A mutation in the 3′-untranslated region of the prothrombin gene and the risk for arterial thrombotic disease. Br J Haematol 104:50–54PubMedCrossRefGoogle Scholar
  69. Franco RF, Reitsma PH (2001) Gene polymorphisms of the haemostatic system and the risk of arterial thrombotic disease. Br J Haematol 115:491–506PubMedCrossRefGoogle Scholar
  70. Frank-Kamenetsky M, Grefhorst A, Anderson NN, Racie TS, Bramlage B, Akinc A, Butler D, Charisse K, Dorkin R, Fan Y, Gamba-Vitalo C, Hadwiger P, Jayaraman M, John M, Jayaprakash KN, Maier M, Nechev L, Rajeev KG, Read T, Röhl I, Soutschek J, Tan P, Wong J, Wang G, Zimmermann T, de Fougerolles A, Vornlocher HP, Langer R, Anderson DG, Manoharan M, Koteliansky V, Horton JD, Fitzgerald K (2008) Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci USA 105(33):11915–11920PubMedCrossRefGoogle Scholar
  71. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, Perry JR, Elliott KS, Lango H, Rayner NW, Shields B, Harries LW, Barrett JC, Ellard S, Groves CJ, Knight B, Patch AM, Ness AR, Ebrahim S, Lawlor DA, Ring SM, Ben-Shlomo Y, Jarvelin MR, Sovio U, Bennett AJ, Melzer D, Ferrucci L, Loos RJ, Barroso I, Wareham NJ, Karpe F, Owen KR, Cardon LR, Walker M, Hitman GA, Palmer CN, Doney AS, Morris AD, Smith GD, Hattersley AT, McCarthy MI (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826):889–894PubMedCrossRefGoogle Scholar
  72. Friso S, Lotto V, Choi SW, Girelli D, Pinotti M, Guarini P, Udali S, Pattini P, Pizzolo F, Martinelli N, Corrocher R, Bernardi F, Olivieri O (2012) Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease. J Med Genet 49(3):192–199PubMedCrossRefGoogle Scholar
  73. Fujisawa T, Ikegami H, Kawaguchi Y, Ogihara T (1998) Meta-analysis of the association of Trp64Arg polymorphism of beta 3-adrenergic receptor gene with body mass index. J Clin Endocrinol Metab 83(7):2441–2444PubMedCrossRefGoogle Scholar
  74. Funk M, Endler G, Lalouschek W, Hsieh K, Schillinger M, Lang W, Mannhalter C (2006) Factor VII gene haplotypes and risk of ischemic stroke. Clin Chem 52(6):1190–1192PubMedCrossRefGoogle Scholar
  75. Galasso G, Santulli G, Piscione F, De Rosa R, Trimarco V, Piccolo R, Cassese S, Iaccarino G, Trimarco B, Chiariello M (2010) The GPIIIA PlA2 polymorphism is associated with an increased risk of cardiovascular adverse events. BMC Cardiovasc Disord 10:41PubMedCrossRefGoogle Scholar
  76. Gehring NH, Frede U, Neu-Yilik G, Hundsdoerfer P, Vetter B, Hentze MW, Kulozik AE (2001) Increased efficiency of mRNA 3′ end formation: a new genetic mechanism contributing to hereditary thrombophilia. Nat Genet 28:389–392PubMedCrossRefGoogle Scholar
  77. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schäfer H, Hinney A, Hebebrand J (2004) Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 74(3):572–581PubMedCrossRefGoogle Scholar
  78. Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, Manzato F, Mazzucco A, Bernardi F, Corrocher R (2000) Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 343:774–780PubMedCrossRefGoogle Scholar
  79. Gjesing AP, Andersen G, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O (2008) Association of the beta3-adrenergic receptor Trp64Arg polymorphism with common metabolic traits: studies of 7605 middle-aged white people. Mol Genet Metab 94(1):90–97PubMedCrossRefGoogle Scholar
  80. Gloyn AL, Noordam K, Willemsen MA, Ellard S, Lam WW, Campbell IW, Midgley P, Shiota C, Buettger C, Magnuson MA, Matschinsky FM, Hattersley AT (2003) Insights into the biochemical and genetic basis of glucokinase activation from naturally occurring hypoglycemia mutations. Diabetes 52(9):2433–2440PubMedCrossRefGoogle Scholar
  81. Gong LL, Peng JH, Han FF, Zhu J, Fang LH, Wang YH, Du GH, Wang HY, Liu LH (2012) Association of tissue plasminogen activator and plasminogen activator inhibitor polymorphism with myocardial infarction: A meta-analysis. Thromb Res 130(3):e43–e51PubMedCrossRefGoogle Scholar
  82. Gouda HN, Sagoo GS, Harding A-J, Yates J, Sandhu MS, Higgins JPT (2010) The Association Between the Peroxisome Proliferator-Activated Receptor-g2 (PPARG2) Pro12Ala Gene Variant and Type 2 Diabetes Mellitus: A HuGE Review and Meta-Analysis. Am J Epidemiol 171:645–655PubMedCrossRefGoogle Scholar
  83. Grant PJ, Humphries S (1999) Genetic determinants of arterial thrombosis. Baillieres Best Pract Res Clin Haematol 12:505–532PubMedCrossRefGoogle Scholar
  84. Grant SF, Thorleifsson G, Reynisdottir I, Benediktsson R, Manolescu A, Sainz J, Helgason A, Stefansson H, Emilsson V, Helgadottir A, Styrkarsdottir U, Magnusson KP, Walters GB, Palsdottir E, Jonsdottir T, Gudmundsdottir T, Gylfason A, Saemundsdottir J, Wilensky RL, Reilly MP, Rader DJ, Bagger Y, Christiansen C, Gudnason V, Sigurdsson G, Thorsteinsdottir U, Gulcher JR, Kong A, Stefansson K (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38(3):320–323PubMedCrossRefGoogle Scholar
  85. Greisenegger S, Weber M, Funk M, Endler G, Lang W, Ferrari J, Lalouschek W, Mannhalter C (2007) Polymorphisms in the coagulation factor VII gene and risk of primary intracerebral hemorrhage. Eur J Neurol 14(10):1098–1101PubMedCrossRefGoogle Scholar
  86. Gudbjartsson DF, Arnar DO, Helgadottir A, Gretarsdottir S, Holm H, Sigurdsson A, Jonasdottir A, Baker A, Thorleifsson G, Kristjansson K, Palsson A, Blondal T, Sulem P, Backman VM, Hardarson GA, Palsdottir E, Helgason A, Sigurjonsdottir R, Sverrisson JT, Kostulas K, Ng MC, Baum L, So WY, Wong KS, Chan JC, Furie KL, Greenberg SM, Sale M, Kelly P, MacRae CA, Smith EE, Rosand J, Hillert J, Ma RC, Ellinor PT, Thorgeirsson G, Gulcher JR, Kong A, Thorsteinsdottir U, Stefansson K (2007) Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature 448:353–357PubMedCrossRefGoogle Scholar
  87. Guella I, Duga S, Ardissino D, Merlini PA, Peyvandi F, Mannucci PM, Asselta R (2011) Common variants in the haemostatic gene pathway contribute to risk of early-onset myocardial infarction in the Italian population. Thromb Haemost 106(4):655–664PubMedCrossRefGoogle Scholar
  88. Guevara J Jr, Spurlino J, Jan AY, Yang CY, Tulinsky A, Prasad BV, Gaubatz JW, Morrisett JD (1993) Proposed mechanisms for binding of apo[a] kringle type 9 to apo B-100 in human lipoprotein[a]. Biophys J 64(3):686–700PubMedCrossRefGoogle Scholar
  89. Hasan N, McColgan P, Bentley P, Edwards RJ, Sharma P (2012) Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review. Br J Clin Pharmacol 74(2):230–240PubMedCrossRefGoogle Scholar
  90. Heid IM, Vollmert C, Hinney A, Döring A, Geller F, Löwel H, Wichmann HE, Illig T, Hebebrand J, Kronenberg F, Group KORA (2005) Association of the 103I MC4R allele with decreased body mass in 7937 participants of two population based surveys. J Med Genet 42(4):e21PubMedCrossRefGoogle Scholar
  91. Heike Münzberg H, Myers MG (2005) Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 8(5):566–570PubMedCrossRefGoogle Scholar
  92. Heinrich J, Balleisen L, Schulte H, Assmann G, van de Loo J (1994) Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men. Arterioscler Thromb 14:54–59PubMedCrossRefGoogle Scholar
  93. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitchell RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE (2012) Truncations of titin causing dilated cardiomyopathy. New Engl J Med 366:619–628PubMedCrossRefGoogle Scholar
  94. Hinney A, Hebebrand J (2008) Polygenic Obesity in Humans. Obes Facts 1:35–42PubMedCrossRefGoogle Scholar
  95. Hoekstra T, Geleijnse JM, Schouten EG, Kluft C (2004) Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb Haemost 91(5):861–872PubMedGoogle Scholar
  96. Holm H, Gudbjartsson DF, Arnar DO, Thorleifsson G, Thorgeirsson G, Stefansdottir H, Gudjonsson SA, Jonasdottir A, Mathiesen EB, Njølstad I, Nyrnes A, Wilsgaard T, Hald EM, Hveem K, Stoltenberg C, Løchen ML, Kong A, Thorsteinsdottir U, Stefansson K (2010) Several common variants modulate heart rate, PR interval and QRS duration. Nat Genet 42(2):117–122PubMedCrossRefGoogle Scholar
  97. Horton JD, Cohen JC, Hobbs HH (2007) Molecular biology of PCSK9: its role in LDL metabolism. Trends Biochem Sci 32(2):71–77PubMedCrossRefGoogle Scholar
  98. Horton JD, Cohen JC, Hobbs HH (2009) PCSK9: a convertase that coordinates LDL catabolism. J Lipid Res 50(Suppl):S172–S177PubMedGoogle Scholar
  99. Hsieh K, Lalouschek W, Schillinger M, Endler G, Reisinger M, Janisiw M, Lang W, Cheng S, Wagner O, Mannhalter C (2005) Impact of alphaENaC polymorphisms on the risk of ischemic cerebrovascular events: a multicenter case–control study. Clin Chem 51(6):952–956PubMedCrossRefGoogle Scholar
  100. Iacoviello L, Di Castelnuovo A, De Knijff P, D′Orazio A, Amore C, Arboretti R, Kluft C, Benedetta Donati M (1998) Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 338:79–85PubMedCrossRefGoogle Scholar
  101. Iwabu M, Yamauchi T, Okada-Iwabu M, Sato K, Nakagawa T, Funata M, Yamaguchi M, Namiki S, Nakayama R, Tabata M, Ogata H, Kubota N, Takamoto I, Hayashi YK, Yamauchi N, Waki H, Fukayama M, Nishino I, Tokuyama K, Ueki K, Oike Y, Ishii S, Hirose K, Shimizu T, Touhara K, Kadowaki T (2010) Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature 464(7293):1313–1319PubMedCrossRefGoogle Scholar
  102. Jeninga EH, Gurnell M, Kalkhoven E (2009) Functional implications of genetic variation in human PPARg. Trends Endocrinol Metab 20(8):380–387PubMedCrossRefGoogle Scholar
  103. Johnson CY, Tuite A, Morange PE, Tregouet DA, Gagnon F (2011a) The factor XII -4C>T variant and risk of common thrombotic disorders: A HuGE review and meta-analysis of evidence from observational studies. Am J Epidemiol 173(2):136–144PubMedCrossRefGoogle Scholar
  104. Johnson T, Gaunt TR, Newhouse SJ et al (2011b) Blood pressure loci identified with a gene-centric array. Am J Hum Genet 89(6):688–700PubMedCrossRefGoogle Scholar
  105. Jood K, Ladenvall P, Tjärnlund-Wolf A, Ladenvall C, Andersson M, Nilsson S, Blomstrand C, Jern C (2005) Fibrinolytic gene polymorphism and ischemic stroke. Stroke 36(10):2077–2081PubMedCrossRefGoogle Scholar
  106. Juul K, Tybjaerg-Hansen A, Steffensen R, Kofoed S, Jensen G, Nordestgaard BG (2002) Factor V Leiden: the Copenhagen City Heart Study and 2 meta-analyses. Blood 100:3–10PubMedCrossRefGoogle Scholar
  107. Kääb S, Crawford DC, Sinner MF, Behr ER, Kannankeril PJ, Wilde AA, Bezzina CR, Schulze-Bahr E, Guicheney P, Bishopric NH, Myerburg RJ, Schott JJ, Pfeufer A, Beckmann BM, Martens E, Zhang T, Stallmeyer B, Zumhagen S, Denjoy I, Bardai A, Van Gelder IC, Jamshidi Y, Dalageorgou C, Marshall V, Jeffery S, Shakir S, Camm AJ, Steinbeck G, Perz S, Lichtner P, Meitinger T, Peters A, Wichmann HE, Ingram C, Bradford Y, Carter S, Norris K, Ritchie MD, George AL Jr, Roden DM (2012) A large candidate gene survey identifies the KCNE1 D85N polymorphism as a possible modulator of drug-induced torsades de pointes. Circ Cardiovasc Genet 5(1):91–99PubMedCrossRefGoogle Scholar
  108. Kamphuisen PW, Houwing-Duistermaat JJ, van Houwelingen HC, Eikenboom JC, Bertina RM, Rosendaal FR (1998) Familial clustering of factor VIII and von Willebrand factor levels. Thromb Haemost 79:323–327PubMedGoogle Scholar
  109. Kamstrup PR (2010) Lipoprotein(a) and ischemic heart disease – a causal association? A review. Atherosclerosis 211(1):15–23PubMedCrossRefGoogle Scholar
  110. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, Niho Y (1998) A common genetic polymorphism (46C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 91:2010–2014PubMedGoogle Scholar
  111. Karelis AD, Brochu M, Rabasa-Lhoret R (2004) Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 30(6):569–572PubMedCrossRefGoogle Scholar
  112. Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Bergman RN, Sundvall J, Laakso M, Ferrucci L, Scheet P, Sanna S, Uda M, Yang Q, Lunetta KL, Dupuis J, de Bakker PI, O’Donnell CJ, Chambers JC, Kooner JS, Hercberg S, Meneton P, Lakatta EG, Scuteri A, Schlessinger D, Tuomilehto J, Collins FS, Groop L, Altshuler D, Collins R, Lathrop GM, Melander O, Salomaa V, Peltonen L, Orho-Melander M, Ordovas JM, Boehnke M, Abecasis GR, Mohlke KL, Cupples LA (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41(1):56–65PubMedCrossRefGoogle Scholar
  113. Ken-Dror G, Drenos F, Humphries SE, Talmud PJ, Hingorani AD, Kivimäki M, Kumari M, Bauer KA, Morrissey JH, Ireland HA (2010) Haplotype and genotype effects of the F7 gene on ­circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men. J Thromb Haemost 8(11):2394–2403PubMedCrossRefGoogle Scholar
  114. Kim J, Basak JM, Holtzman DM (2009) The role of apolipoprotein E in Alzheimer’s disease. Neuron 63(3):287–303PubMedCrossRefGoogle Scholar
  115. Kim RJ, Becker RC (2003) Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies. Am Heart J 146(6):948–957PubMedCrossRefGoogle Scholar
  116. Kirchhof P, Kahr PC, Kaese S, Piccini I, Vokshi I, Scheld HH, Rotering H, Fortmueller L, Laakmann S, Verheule S, Schotten U, Fabritz L, Brown NA (2011) PITX2c is expressed in the adult left atrium, and reducing Pitx2c expression promotes atrial fibrillation inducibility and complex changes in gene expression. Circ Cardiovasc Genet 4:123–133PubMedCrossRefGoogle Scholar
  117. Kjolby M, Andersen OM, Breiderhoff T, Fjorback AW, Pedersen KM, Madsen P, Jansen P, Heeren J, Willnow TE, Nykjaer A (2010) Sort1, encoded by the cardiovascular risk locus 1p13.3, is a regulator of hepatic lipoprotein export. Cell Metab 12(3):213–223PubMedCrossRefGoogle Scholar
  118. Knowles JW, Wang H, Itakura H, Southwick A, Myers RM, Iribarren C, Fortmann SP, Go AS, Quertermous T, Hlatky MA (2007) Association of polymorphisms in platelet and hemostasis system genes with acute myocardial infarction. Am Heart J 154(6):1052–1058PubMedCrossRefGoogle Scholar
  119. Kohler HP, Grant PJ (1999) The role of factor XIII Val34Leu in cardiovascular disease. QJM 92:67–72PubMedCrossRefGoogle Scholar
  120. Kolder IC, Tanck MW, Bezzina CR (2012) Common genetic variation modulating cardiac ECG parameters and susceptibility to sudden cardiac death. J Mol Cell Cardiol 52:620–629PubMedCrossRefGoogle Scholar
  121. Kraft HG, Lingenhel A, Köchl S, Hoppichler F, Kronenberg F, Abe A, Mühlberger V, Schönitzer D, Utermann G (1996a) Apolipoprotein(a) kringle IV repeat number predicts risk for coronary heart disease. Arterioscler Thromb Vasc Biol 16(6):713–719PubMedCrossRefGoogle Scholar
  122. Kraft HG, Lingenhel A, Pang RW, Delport R, Trommsdorff M, Vermaak H, Janus ED, Utermann G (1996b) Frequency distributions of apolipoprotein(a) kringle IV repeat alleles and their effects on lipoprotein(a) levels in Caucasian, Asian, and African populations: the distribution of null alleles is non-random. Eur J Hum Genet 4(2):74–87PubMedGoogle Scholar
  123. Kucharska-Newton AM, Monda KL, Campbell S, Bradshaw PT, Wagenknecht LE, Boerwinkle E, Wasserman BA, Heiss G (2011) Association of the platelet GPIIb/IIIa polymorphism with atherosclerotic plaque morphology: the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis 216(1):151–156PubMedCrossRefGoogle Scholar
  124. Kudaravalli R, T T, Pinotti M, Ratti A, Santacroce R, Margaglione M, Dallapiccola B, Bernardi F, Fortina P, Devoto M, Pollak ES (2002) Polymorphic changes in the 5¢ flanking region of factor VII have a combined effect on promoter strength. Thromb Haemost 88:763–767PubMedGoogle Scholar
  125. Kunes J, Zicha J (2009) The interaction of genetic and environmental factors in the etiology of hypertension. Physiol Res 58:S33–S41PubMedGoogle Scholar
  126. Kunicki TJ (2002) The influence of platelet collagen receptor polymorphisms in hemostasis and thrombotic disease. Arterioscler Thromb Vasc Biol 22:14–20PubMedCrossRefGoogle Scholar
  127. Kunicki TJ, Williams SA, Salomon DR, Harrison P, Crisler P, Nakagawa P, Mondala TS, Head SR, Nugent DJ (2009) Genetics of platelet reactivity in normal, healthy individuals. J Thromb Haemost 7(12):2116–2122PubMedCrossRefGoogle Scholar
  128. Kunicki TJ, Williams SA, Diaz D, Farndale RW, Nugent DJ (2012) Platelet adhesion to decorin but not collagen I correlates with the integrin α2 dimorphism E534K, the basis of the human platelet alloantigen (HPA)-5 system. Haematologica 97(5):692–695PubMedCrossRefGoogle Scholar
  129. Kurokawa N, Nakai K, Kameo S, Liu ZM, Satoh H (2001) Association of BMI with the beta3-adrenergic receptor gene polymorphism in Japanese: meta-analysis. Obes Res 9(12):741–745PubMedCrossRefGoogle Scholar
  130. Kurokawa N, Young EH, Oka Y, Satoh H, Wareham NJ, Sandhu MS, Loos RJ (2008) The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int J Obes (Lond) 32(8):1240–1249CrossRefGoogle Scholar
  131. Lalouschek W, Schillinger M, Hsieh K, Endler G, Tentschert S, Lang W, Cheng S, Mannhalter C (2005) Matched case–control study on factor V Leiden and the prothrombin G20210A mutation in patients with ischemic stroke/transient ischemic attack up to the age of 60 years. Stroke 36(7):1405–1409PubMedCrossRefGoogle Scholar
  132. Lanktree MB, Dichgans M, Hegele RA (2010) Advances in genomic analysis of stroke: what have we learned and where are we headed? Stroke 41(4):825–832PubMedCrossRefGoogle Scholar
  133. Lee AJ, Lowe GD, Woodward M, Tunstall-Pedoe H (1993) Fibrinogen in relation to personal history of prevalent hypertension, diabetes, stroke, intermittent claudication, coronary heart disease, and family history: the Scottish Heart Health Study. Br Heart J 69:338–342PubMedCrossRefGoogle Scholar
  134. Lehmann ED, Hopkins KD, Parker JR, Gosling RS (1995) Hyperlipidaemia, hypertension, and coronary heart disease. Lancet 345(8953):863PubMedCrossRefGoogle Scholar
  135. Lewandowski K, Swierczyńska A, Kwaśnikowski P, Elikowski W, Rzeźniczak M (2005) The prevalence of C807T mutation of glycoprotein Ia gene among young male survivors of myocardial infarction: a relation with coronary angiography results. Kardiol Pol 63:107–113PubMedGoogle Scholar
  136. Li D, Tapscoft T, Gonzalez O, Burch PE, Quiñones MA, Zoghbi WA, Hill R, Bachinski LL, Mann DL, Roberts R (1999) Desmin mutation responsible for idiopathic dilated cardiomyopathy. Circulation 100(5):461–464PubMedCrossRefGoogle Scholar
  137. Li H, Chen Y, Zhou B, Peng Y, Sheng Y, Rao L (2011) Polymorphisms of presenilin-1 gene associate with dilated cardiomyopathy susceptibility. Mol Cell Biochem 358(1–2):31–36PubMedGoogle Scholar
  138. Lingrel JB (2010) The physiological significance of the cardiotonic steroid/ouabain-binding site of the Na, K-ATPase. Ann Rev Physiol 72:395–412CrossRefGoogle Scholar
  139. Linsel-Nitschke P, Heeren J, Aherrahrou Z, Bruse P, Gieger C, Illig T, Prokisch H, Heim K, Doering A, Peters A, Meitinger T, Wichmann HE, Hinney A, Reinehr T, Roth C, Ortlepp JR, Soufi M, Sattler AM, Schaefer J, Stark K, Hengstenberg C, Schaefer A, Schreiber S, Kronenberg F, Samani NJ, Schunkert H, Erdmann J (2010) Genetic variation at chromosome 1p13.3 affects sortilin mRNA expression, cellular LDL-uptake and serum LDL levels which translates to the risk of coronary artery disease. Atherosclerosis 208(1):183–189PubMedCrossRefGoogle Scholar
  140. Liu X, Wang F, Knight AC, Zhao J, Xiao J (2012) Common variants for atrial fibrillation: results from genome-wide association studies. Hum Genet 131(1):33–39PubMedCrossRefGoogle Scholar
  141. Lopaciuk S, Bykowska K, Kwiecinski H, Mickielewicz A, Czlonkowska A, Mendel T, Kuczynska-Zardzewialy A, Szelagowska D, Windyga J, Schröder W, Herrmann FH, Jedrzejowska H (2001) Factor V Leiden, prothrombin gene G20210A variant, and methylenetetrahydrofolate reductase C677T genotype in young adults with ischemic stroke. Clin Appl Thromb Hemost 7:346–350PubMedCrossRefGoogle Scholar
  142. Loscalzo J, Weinfeld M, Fless GM, Scanu AM (1990) Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 10(2):240–245PubMedCrossRefGoogle Scholar
  143. Lotta LA, Wang M, Yu J, Martinelli I, Yu F, Passamonti SM, Consonni D, Pappalardo E, Menegatti M, Scherer SE, Lewis LL, Akbar H, Wu Y, Bainbridge MN, Muzny DM, Mannucci PM, Gibbs RA, Peyvandi F (2012) Identification of genetic risk variants for deep vein thrombosis by multiplexed next-generation sequencing of 186 hemostatic/pro-inflammatory genes. BMC Med Genomics 5:7PubMedCrossRefGoogle Scholar
  144. Lovely RS, Yang Q, Massaro JM, Wang J, D’Agostino RB Sr, O’Donnell CJ, Shannon J, Farrell DH (2011) Assessment of genetic determinants of the association of γ′ fibrinogen in relation to cardiovascular disease. Arterioscler Thromb Vasc Biol 31(10):2345–2352PubMedCrossRefGoogle Scholar
  145. Luke MM, Kane JP, Liu DM, Rowland CM, Shiffman D, Cassano J, Catanese JJ, Pullinger CR, Leong DU, Arellano AR, Tong CH, Movsesyan I, Naya-Vigne J, Noordhof C, Feric NT, Malloy MJ, Topol EJ, Koschinsky ML, Devlin JJ, Ellis SG (2007) A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 27(9):2030–2036PubMedCrossRefGoogle Scholar
  146. Macko RF, Kittner SJ, Epstein A, Cox DK, Wozniak MA, Wityk RJ, Stern BJ, Sloan MA, Sherwin R, Price TR, McCarter RJ, Johnson CJ, Earley CJ, Buchholz DW, Stolley PD (1999) Elevated tissue plasminogen activator antigen and stroke risk. The stroke prevention in young women study. Stroke 30:7–11PubMedCrossRefGoogle Scholar
  147. Maes HH, Neale MC, Eaves LJ (1997) Genetic and environmental factors in relative body weight and human obesity. Behav Genet 27:325–351PubMedCrossRefGoogle Scholar
  148. Maitland-van der Zee AH, Peters BJ, Lynch AI, Boerwinkle E, Arnett DK, Cheng S, Davis BR, Leiendecker-Foster C, Ford CE, Eckfeldt JH (2009) The effect of nine common polymorphisms in coagulation factor genes (F2, F5, F7, F12 and F13) on the effectiveness of statins: the GenHAT study. Pharmacogenet Genomics 19(5):338–344PubMedCrossRefGoogle Scholar
  149. Männikkö R, Overend G, Perrey C, Gavaghan CL, Valentin JP, Morten J, Armstrong M, Pollard CE (2010) Pharmacological and electrophysiological characterization of nine, single nucleotide polymorphisms of the hERG-encoded potassium channel. Br J Pharmacol 159(1):102–114PubMedCrossRefGoogle Scholar
  150. Martínez-Calatrava MJ, González-Sánchez JL, Zabena C, Martínez-Larrad MT, Luque-Otero M, Serrano-Ríos M (2007) Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain. J Hypertens 25(4):773–777PubMedCrossRefGoogle Scholar
  151. Masuzaki H, Tanaka T, Ebihara K, Hosoda K, Nakao K (2009) Hypothalamic melanocortin signaling and leptin resistance–perspective of therapeutic application for obesity-diabetes syndrome. Peptides 30(7):1383–1386PubMedCrossRefGoogle Scholar
  152. Matkovich SJ, Van Booven DJ, Hindes A, Kang MY, Druley TE, Vallania FL, Mitra RD, Reilly MP, Cappola TP, Dorn GW 2nd (2010) Cardiac signaling genes exhibit unexpected sequence diversity in sporadic cardiomyopathy, revealing HSPB7 polymorphisms associated with disease. J Clin Invest 120:280–289PubMedCrossRefGoogle Scholar
  153. Meade TW, Ruddock V, Stirling Y, Chakrabarti R, Miller GJ (1993) Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study. Lancet 342:1076–1079PubMedCrossRefGoogle Scholar
  154. Mikkola H, Syrjälä M, Rasi V, Vahtera E, Hämäläinen E, Peltonen L, Palotie A (1994) Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 84:517–525PubMedGoogle Scholar
  155. Mohana VU, Swapna N, Surender RS, Vishnupriya S, Padma T (2012) Gender-related association of AGT gene variants (M235T and T174M) with essential hypertension–a case–control study. Clin Exp Hypertens 34(1):38–44PubMedCrossRefGoogle Scholar
  156. Monkovic DD, Tracy PB (1990) Activation of human factor V by factor Xa and thrombin. Biochemistry 29:1118–1128PubMedCrossRefGoogle Scholar
  157. Morandi A, Maffeis C, Lobbens S, Bouatia-Naji N, Heude B, Pinelli L, Meyre D, Froguel P (2010) Early detrimental metabolic outcomes of rs17300539-A allele of ADIPOQ gene despite higher adiponectinemia. Obesity (Silver Spring) 18(7):1469–1473CrossRefGoogle Scholar
  158. Morris BJ (2011) A “SNP in time” for SCNN1G to join the “highly likely” list of genes for essential hypertension. Hypertension 58(6):996–997PubMedCrossRefGoogle Scholar
  159. Mottillo S, Filion KB, Genest J, Joseph L, Pilote L, Poirier P, Rinfret S, Schiffrin EL, Eisenberg MJ (2010) The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 56:1113–1132PubMedCrossRefGoogle Scholar
  160. Mulholland DJ, Dedhar S, Coetzee GA, Nelson CC (2005) Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? Endocr Rev 26(7):898–915PubMedCrossRefGoogle Scholar
  161. Münzberg H, Björnholm M, Bates SH, Myers MG (2005) Leptin receptor action and mechanisms of leptin resistance. Cell Mol Life Sci 62:642–652PubMedCrossRefGoogle Scholar
  162. Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, Li X, Li H, Kuperwasser N, Ruda VM, Pirruccello JP, Muchmore B, Prokunina-Olsson L, Hall JL, Schadt EE, Morales CR, Lund-Katz S, Phillips MC, Wong J, Cantley W, Racie T, Ejebe KG, Orho-Melander M, Melander O, Koteliansky V, Fitzgerald K, Krauss RM, Cowan CA, Kathiresan S, Rader DJ (2010) From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466(7307):714–719PubMedCrossRefGoogle Scholar
  163. Ned RM, Yesupriya A, Imperatore G, Smelser DT, Moonesinghe R, Chang MH, Dowling NF (2012) The ACE I/D polymorphism in US adults: limited evidence of association with hypertension-related traits and sex-specific effects by race/ethnicity. Am J Hypertens 25(2):209–215PubMedCrossRefGoogle Scholar
  164. Nielsen EM, Hansen L, Echwald SM, Drivsholm T, Borch-Johnsen K, Ekstrøm CT, Hansen T, Pedersen O (2003) Evidence for an association between the Leu162Val polymorphism of the PPARalpha gene and decreased fasting serum triglyceride levels in glucose tolerant subjects. Pharmacogenetics 13(7):417–423PubMedCrossRefGoogle Scholar
  165. Nielsen MS, Madsen P, Christensen EI, Nykjaer A, Gliemann J, Kasper D, Pohlmann R, Petersen CM (2001) The sortilin cytoplasmic tail conveys Golgi-endosome transport and binds the VHS domain of the GGA2 sorting protein. EMBO J 20(9):2180–2190PubMedCrossRefGoogle Scholar
  166. Nishio Y, Makiyama T, Itoh H, Sakaguchi T, Ohno S, Gong YZ, Yamamoto S, Ozawa T, Ding WG, Toyoda F, Kawamura M, Akao M, Matsuura H, Kimura T, Kita T, Horie M (2009) D85N, a KCNE1 polymorphism, is a disease-causing gene variant in long QT syndrome. J Am Coll Cardiol 54:812–819PubMedCrossRefGoogle Scholar
  167. Norton N, Li D, Rieder MJ, Siegfried JD, Rampersaud E, Züchner S, Mangos S, Gonzalez-Quintana J, Wang L, McGee S, Reiser J, Martin E, Nickerson DA, Hershberger RE (2011) Genome-wide studies of copy number variation and exome sequencing identify rare variants in BAG3 as a cause of dilated cardiomyopathy. Am J Hum Genet 88(3):273–282PubMedCrossRefGoogle Scholar
  168. Nurden AT (1995) Polymorphisms of human platelet membrane glycoproteins: structure and clinical significance. Thromb Haemost 74:345–351PubMedGoogle Scholar
  169. Oguchi S, Ito D, Murata M, Yoshida T, Tanahashi N, Fukuuchi Y, Ikeda Y, Watanabe K (2000) Genotype distribution of the 46C/T polymorphism of coagulation factor XII in the Japanese population: absence of its association with ischemic cerebrovascular disease. Thromb Haemost 83:178–179PubMedGoogle Scholar
  170. Olson TM, Terzic A (2010) Human KATP channelopathies: diseases of metabolic homeostasis. Pflugers Arch 460:295–306PubMedCrossRefGoogle Scholar
  171. Paavonen KJ, Chapman H, Laitinen PJ, Fodstad H, Piippo K, Swan H, Toivonen L, Viitasalo M, Kontula K, Pasternack M (2003) Functional characterization of the common amino acid 897 polymorphism of the cardiac potassium channel KCNH2 (HERG). Cardiovasc Res 59(3):603–611PubMedCrossRefGoogle Scholar
  172. Papadopoulou S, Edlund H (2005) Attenuated Wnt signaling perturbs pancreatic growth but not pancreatic function. Diabetes 54(10):2844–2851PubMedCrossRefGoogle Scholar
  173. Parson W, Kraft HG, Niederstätter H, Lingenhel AW, Köchl S, Fresser F, Utermann G (2004) A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a). Hum Mutat 24(6):474–480PubMedCrossRefGoogle Scholar
  174. Pellitero S, Reverter JL, Tàssies D, Pizarro E, Monteagudo J, Salinas I, Aguilera E, Sanmartí A, Reverter JC (2010) Polymorphisms in platelet glycoproteins Ia and IIIa are associated with arterial thrombosis and carotid atherosclerosis in type 2 diabetes. Thromb Haemost 103(3):630–637PubMedCrossRefGoogle Scholar
  175. Penas-Steinhardt A, Tellechea ML, Gomez-Rosso L, Brites F, Frechtel GD, Poskus E (2011) Association of common variants in JAK2 gene with reduced risk of metabolic syndrome and related disorders. BMC Med Genet 12:166PubMedCrossRefGoogle Scholar
  176. Periasamy M, Bhupathy P, Babu GJ (2008) Regulation of sarcoplasmic reticulum Ca2+ ATPase pump expression and its relevance to cardiac muscle physiology and pathology. Cardiovasc Res 77:265–273PubMedCrossRefGoogle Scholar
  177. Perry JR, Frayling TM (2008) New gene variants alter type 2 diabetes risk predominantly through reduced beta-cell function. Curr Opin Clin Nutr Metab Care 11(4):371–377PubMedCrossRefGoogle Scholar
  178. Poelmann RE, Jongbloed MR, Gittenberger-de Groot AC (2008) Pitx2: a challenging teenager. Circ Res 102:749–751PubMedCrossRefGoogle Scholar
  179. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM (1996) A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88:3698–3703PubMedGoogle Scholar
  180. Prunier C, Hocevar BA, Howe PH (2004) Wnt signaling: physiology and pathology. Growth Factors 22(3):141–150PubMedCrossRefGoogle Scholar
  181. Raffai RL, Dong LM, Farese RV Jr, Weisgraber KH (2001) Introduction of human apolipoprotein E4 “domain interaction” into mouse apolipoprotein E. Proc Natl Acad Sci USA A98(20):11587–11591CrossRefGoogle Scholar
  182. Rask-Andersen M, Almén MS, Olausen HR, Olszewski PK, Eriksson J, Chavan RA, Levine AS, Fredriksson R, Schiöth HB (2011) Functional coupling analysis suggests link between the obesity gene FTO and the BDNF-NTRK2 signaling pathway. BMC Neurosci 12:117PubMedCrossRefGoogle Scholar
  183. Reaven GM (1988) (1988) Banting lecture. Role of insulin resistance in human disease. Diabetes 37:1595–1607PubMedCrossRefGoogle Scholar
  184. Reiner AP, Carlson CS, Thyagarajan B, Rieder MJ, Polak JF, Siscovick DS, Nickerson DA, Jacobs DR Jr, Gross MD (2008) Soluble P-selectin, SELP polymorphisms, and atherosclerotic risk in European-American and African-African young adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Arterioscler Thromb Vasc Biol 28(8):1549–1555PubMedCrossRefGoogle Scholar
  185. Reiner AP, Lange LA, Smith NL, Zakai NA, Cushman M, Folsom AR (2009) Common hemostasis and inflammation gene variants and venous thrombosis in older adults from the Cardiovascular Health Study. J Thromb Haemost 7(9):1499–1505PubMedCrossRefGoogle Scholar
  186. Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF, Van Gelder IC, Ellinor PT, Benjamin EJ (2012) Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities. Circulation 125(23):2933–2943PubMedCrossRefGoogle Scholar
  187. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT Jr, Raghunathan TE, Koepsell TD, Reitsma PH (1997) Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 89:2817–2821PubMedGoogle Scholar
  188. Rulifson IC, Karnik SK, Heiser PW, ten Berge D, Chen H, Gu X, Taketo MM, Nusse R, Hebrok M, Kim SK (2007) Wnt signaling regulates pancreatic beta cell proliferation. Proc Natl Acad Sci USA 104(15):6247–6252PubMedCrossRefGoogle Scholar
  189. Saidi S, Slamia LB, Mahjoub T, Ammou SB, Almawi WY (2007) Association of PAI-1 4G/5G and −844G/A gene polymorphism and changes in PAI-1/tPA levels in stroke: a case–control study. J Stroke Cerebrovasc Dis 16(4):153–159PubMedCrossRefGoogle Scholar
  190. Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG (2000) Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med 133:81–91PubMedCrossRefGoogle Scholar
  191. Sanna S, Li B, Mulas A, Sidore C, Kang HM, Jackson AU, Piras MG, Usala G, Maninchedda G, Sassu A, Serra F, Palmas MA, Wood WH 3rd, Njølstad I, Laakso M, Hveem K, Tuomilehto J, Lakka TA, Rauramaa R, Boehnke M, Cucca F, Uda M, Schlessinger D, Nagaraja R, Abecasis GR (2011) Fine mapping of five loci associated with low-density lipoprotein cholesterol detects variants that double the explained heritability. PLoS Genet 7(7):e1002198PubMedCrossRefGoogle Scholar
  192. Satra M, Samara M, Wozniak G, Tzavara C, Kontos A, Valotassiou V, Vamvakopoulos NK, Tsougos I, Aleporou-Marinou V, Patrinos GP, Kollia P, Georgoulias P (2011) Sequence ­variations in the FII, FV, F13A1, FGB and PAI-1 genes are associated with differences in myocardial perfusion. Pharmacogenomics 12(2):195–203PubMedCrossRefGoogle Scholar
  193. Savage B, Saldivar E, Ruggeri Z (1996) Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor. Cell 84:289–297PubMedCrossRefGoogle Scholar
  194. Schiffrin EL (2005) Peroxisome proliferator-activated receptors and cardiovascular remodeling. Am J Physiol Heart Circ Physiol 288(3):H1037–H1043PubMedCrossRefGoogle Scholar
  195. Schild L (2010) The epithelial sodium channel and the control of sodium balance. Biochim Biophys Acta 1802(12):1159–1165PubMedCrossRefGoogle Scholar
  196. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, Wilde AA, Escande D, Mannens MM, Le Marec H (1999) Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 23(1):20–21PubMedCrossRefGoogle Scholar
  197. Schunkert H, Erdmann J, Samani NJ (2010) Genetics of myocardial infarction: a progress report. Eur Heart J 31(8):918–925PubMedCrossRefGoogle Scholar
  198. Scuteri A, Sanna S, Chen WM, Uda M, Albai G, Strait J, Najjar S, Nagaraja R, Orrú M, Usala G, Dei M, Lai S, Maschio A, Busonero F, Mulas A, Ehret GB, Fink AA, Weder AB, Cooper RS, Galan P, Chakravarti A, Schlessinger D, Cao A, Lakatta E, Abecasis GR (2007) Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits. PLoS Genet 3:e115PubMedCrossRefGoogle Scholar
  199. Shemirani AH, Pongrácz E, Antalfi B, Adány R, Muszbek L (2010) Factor XIII A subunit Val34Leu polymorphism in patients suffering atherothrombotic ischemic stroke. Thromb Res 126(2):159–162PubMedCrossRefGoogle Scholar
  200. Shinlapawittayatorn K, Du XX, Liu H, Ficker E, Kaufman ES, Deschênes I (2011) A common SCN5A polymorphism modulates the biophysical defects of SCN5A mutations. Heart Rhythm 8(3):455–462PubMedCrossRefGoogle Scholar
  201. Shugart YY, Chen L, Day IN, Lewis SJ, Timpson NJ, Yuan W, Abdollahi MR, Ring SM, Ebrahim S, Golding J, Lawlor DA, Davey-Smith G (2009) Two British women studies replicated the association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) and BMI. Eur J Hum Genet 17(8):1050–1055PubMedCrossRefGoogle Scholar
  202. Siebenlist KR, Meh DA, Mosesson MW (2001) Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost 86(5):1221–1228PubMedGoogle Scholar
  203. Siegerink B, Rosendaal FR, Algra A (2009) Genetic variation in fibrinogen; its relationship to fibrinogen levels and the risk of myocardial infarction and ischemic stroke. J Thromb Haemost 7(3):385–390PubMedCrossRefGoogle Scholar
  204. Silvain J, Pena A, Vignalou JB, Hulot JS, Galier S, Cayla G, Bellemain-Appaix A, Barthélémy O, Beygui F, Bal-dit-Sollier C, Drouet L, Weisel JW, Montalescot G, Collet JP (2011) FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype–phenotype case control study. Thromb Haemost 106(3):511–520PubMedCrossRefGoogle Scholar
  205. Sinner MF, Pfeufer A, Akyol M, Beckmann BM, Hinterseer M, Wacker A, Perz S, Sauter W, Illig T, Näbauer M, Schmitt C, Wichmann HE, Schömig A, Steinbeck G, Meitinger T, Kääb S (2008) The non-synonymous coding IKr-channel variant KCNH2-K897T is associated with atrial fibrillation: results from a systematic candidate gene-based analysis of KCNH2 (HERG). Eur Heart J 29(7):907–914PubMedCrossRefGoogle Scholar
  206. Souto JC, Almasy L, Muñiz-Diaz E, Soria JM, Borrell M, Bayén L, Mateo J, Madoz P, Stone W, Blangero J, Fontcuberta J (2000) Functional effects of the ABO locus polymorphism on plasma levels of von Willebrand factor, factor VIII, and activated partial thromboplastin time. Arterioscler Thromb Vasc Biol 20:2024–2028PubMedCrossRefGoogle Scholar
  207. Slowik A, Dziedzic T, Pera J, Figlewicz DA, Szczudlik A (2005) Coagulation factor XIII Vai34Leu polymorphism in patients with small vessel disease or primary intracerebral hemorrhage. Cerebrovasc Dis 19:165–170PubMedCrossRefGoogle Scholar
  208. Stark K, Esslinger UB, Reinhard W, Petrov G, Winkler T, Komajda M, Isnard R, Charron P, Villard E, Cambien F, Tiret L, Aumont MC, Dubourg O, Trochu JN, Fauchier L, Degroote P, Richter A, Maisch B, Wichter T, Zollbrecht C, Grassl M, Schunkert H, Linsel-Nitschke P, Erdmann J, Baumert J, Illig T, Klopp N, Wichmann HE, Meisinger C, Koenig W, Lichtner P, Meitinger T, Schillert A, König IR, Hetzer R, Heid IM, Regitz-Zagrosek V (2010) Hengstenberg C (2010) Genetic association study identifies HSPB7 as a risk gene for idiopathic dilated cardiomyopathy. PLoS Genet 6(10):e1001167PubMedCrossRefGoogle Scholar
  209. Stein EA, Gipe D, Bergeron J, Gaudet D, Weiss R, Dufour R, Wu R, Pordy R (2012) Effect of a monoclonal antibody to PCSK9, REGN727/SAR236553, to reduce low-density lipoprotein cholesterol in patients with heterozygous familial hypercholesterolaemia on stable statin dose with or without ezetimibe therapy: a phase 2 randomised controlled trial. Lancet 380(9836):29–36PubMedCrossRefGoogle Scholar
  210. Stumvoll M, Tschritter O, Fritsche A, Staiger H, Renn W, Weisser M, Machicao F, Häring H (2002) Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51(1):37–41PubMedCrossRefGoogle Scholar
  211. Stutzmann F, Vatin V, Cauchi S, Morandi A, Jouret B, Landt O, Tounian P, Levy-Marchal C, Buzzetti R, Pinelli L, Balkau B, Horber F, Bougnères P, Froguel P, Meyre D (2007) Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum Mol Genet 16(15):1837–1844PubMedCrossRefGoogle Scholar
  212. Suzuki K, Kuriyama M, Saito T, Ichinose A (1997) Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5’-flanking region. J Clin Invest 99(6):1361–1366PubMedCrossRefGoogle Scholar
  213. Takeda N (2003) Cardiomyopathy: molecular and immunological aspects (review). Int J Mol Med 11(1):13–16PubMedGoogle Scholar
  214. Takeuchi F, Yamamoto K, Katsuya T, Sugiyama T, Nabika T, Ohnaka K, Yamaguchi S, Takayanagi R, Ogihara T, Kato N (2012) Reevaluation of the association of seven candidate genes with blood pressure and hypertension: a replication study and meta-analysis with a larger sample size. Hypertens Res 35(8):825–831PubMedCrossRefGoogle Scholar
  215. Taylor MR, Slavov D, Ku L, Di Lenarda A, Sinagra G, Carniel E, Haubold K, Boucek MM, Ferguson D, Graw SL, Zhu X, Cavanaugh J, Sucharov CC, Long CS, Bristow MR, Lavori P, Mestroni L, ; Familial Cardiomyopathy Registry; BEST (Beta-Blocker Evaluation of Survival Trial) DNA Bank (2007) Prevalence of desmin mutations in dilated cardiomyopathy. Circulation 115(10):1244–1251PubMedGoogle Scholar
  216. Temelkova-Kurktschiev T, Stefanov T (2012) Lifestyle and genetics in obesity and type 2 diabetes. Exp Clin Endocrinol Diabetes 120(1):1–6PubMedCrossRefGoogle Scholar
  217. Tessari A, Pietrobon M, Notte A, Cifelli G, Gage PJ, Schneider MD, Lembo G, Campione M (2008) Myocardial Pitx2 differentially regulates the left atrial identity and ventricular asymmetric remodeling programs. Circ Res 102:813–822PubMedCrossRefGoogle Scholar
  218. Tomaiuolo R, Bellia C, Caruso A, Di Fiore R, Quaranta S, Noto D, Cefalù AB, Di Micco P, Zarrilli F, Castaldo G, Averna MR, Ciaccio M (2012) Prothrombotic gene variants as risk factors of acute myocardial infarction in young women. J Transl Med 10:235PubMedCrossRefGoogle Scholar
  219. Tomaszewski M, Charchar FJ, Barnes T, Gawron-Kiszka M, Sedkowska A, Podolecka E, Kowalczyk J, Rathbone W, Kalarus Z, Grzeszczak W, Goodall AH, Samani NJ, Zukowska-Szczechowska E (2009) A common variant in low density lipoprotein receptor-related protein 6 gene (LRP6) is associated with LDL-cholesterol. Arterioscler Thromb Vasc Biol 29(9):1316–1321PubMedCrossRefGoogle Scholar
  220. Torekov SS, Larsen LH, Andersen G, Albrechtsen A, Glümer C, Borch-Johnsen K, Jørgensen T, Hansen T, Pedersen O (2006) Variants in the 5′ region of the neuropeptide Y receptor Y2 gene (NPY2R) are associated with obesity in 5,971 white subjects. Diabetologia 49(11):2653–2658PubMedCrossRefGoogle Scholar
  221. Trégouët DA, König IR, Erdmann J, Munteanu A, Braund PS, Hall AS, Grosshennig A, Linsel-Nitschke P, Perret C, DeSuremain M, Meitinger T, Wright BJ, Preuss M, Balmforth AJ, Ball SG, Meisinger C, Germain C, Evans A, Arveiler D, Luc G, Ruidavets JB, Morrison C, van der Harst P, Schreiber S, Neureuther K, Schäfer A, Bugert P, El Mokhtari NE, Schrezenmeir J, Stark K, Rubin D, Wichmann HE, Hengstenberg C, Ouwehand W; Wellcome Trust Case Control Consortium; Cardiogenics Consortium, Ziegler A, Tiret L, Thompson JR, Cambien F, Schunkert H, Samani NJ (2009) Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nat Genet 41(3):283–285Google Scholar
  222. Tsantes AE, Nikolopoulos GK, Bagos PG, Bonovas S, Kopterides P, Vaiopoulos G (2008) The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk. Thromb Res 122(6):736–742PubMedCrossRefGoogle Scholar
  223. Van de Water NS, French JK, Lund M, Hyde TA, White HD, Browett PJ (2000) Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol 36:717–722PubMedCrossRefGoogle Scholar
  224. Van der Zwaag PA, van Rijsingen IA, Asimaki A, Jongbloed JD, van Veldhuisen DJ, Wiesfeld AC, Cox MG, van Lochem LT, de Boer RA, Hofstra RM, Christiaans I, van Spaendonck-Zwarts KY, Lekannedit Deprez RH, Judge DP, Calkins H, Suurmeijer AJ, Hauer RN, Saffitz JE, Wilde AA, van den Berg MP, van Tintelen JP (2012) Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy. Eur J Heart Fail 14(11):1199–1207PubMedCrossRefGoogle Scholar
  225. Van Schie MC, van Loon JE, de Maat MP, Leebeek FW (2011) Genetic determinants of von Willebrand factor levels and activity in relation to the risk of cardiovascular disease: a review. J Thromb Haemost 9(5):899–908PubMedCrossRefGoogle Scholar
  226. Vehaskari VM (2009) Heritable forms of hypertension. Pediatr Nephrol 24:1929–1937PubMedCrossRefGoogle Scholar
  227. Viel KR, Machiah DK, Warren DM, Khachidze M, Buil A, Fernstrom K, Souto JC, Peralta JM, Smith T, Blangero J, Porter S, Warren ST, Fontcuberta J, Soria JM, Flanders WD, Almasy L, Howard TE (2007) A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood 109(9):3713–3724PubMedCrossRefGoogle Scholar
  228. Villard E, Perret C, Gary F, Proust C, Dilanian G, Hengstenberg C, Ruppert V, Arbustini E, Wichter T, Germain M, Dubourg O, Tavazzi L, Aumont MC, DeGroote P, Fauchier L, Trochu JN, Gibelin P, Aupetit JF, Stark K, Erdmann J, Hetzer R, Roberts AM, Barton PJ, Regitz-Zagrosek V; Cardiogenics Consortium, Aslam U, Duboscq-Bidot L, Meyborg M, Maisch B, Madeira H, Waldenström A, Galve E, Cleland JG, Dorent R, Roizes G, Zeller T, Blankenberg S, Goodall AH, Cook S, Tregouet DA, Tiret L, Isnard R, Komajda M, Charron P, Cambien F (2011) A genome-wide association study identifies two loci associated with heart failure due to dilated cardiomyopathy. Eur Heart J 32(9):1065–1076Google Scholar
  229. Wang X, Cheng S, Brophy VH, Erlich HA, Mannhalter C, Berger K, Lalouschek W, Browner WS, Shi Y, Ringelstein EB, Kessler C, Luedemann J, Lindpaintner K, Liu L, Ridker PM, Zee RY, Cook NR, ; RMS Stroke SNP Consortium (2009) A meta-analysis of candidate gene ­polymorphisms and ischemic stroke in 6 study populations: association of lymphotoxin-alpha in nonhypertensive patients. Stroke 40:683–695PubMedCrossRefGoogle Scholar
  230. Wang J, Klysik E, Sood S, Johnson RL, Wehrens XH, Martin JF (2010a) Pitx2 prevents susceptibility to atrial arrhythmias by inhibiting left-sided pacemaker specification. Proc Natl Acad Sci USA 107:9753–9758PubMedCrossRefGoogle Scholar
  231. Wang Y, Fu W, Xie F, Wang Y, Chu X, Wang H, Shen M, Wang Y, Wang Y, Sun W, Lei R, Yang L, Wu H, Foo J, Liu J, Jin L, Huang W (2010b) Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population. J Hum Genet 55(8):490–494PubMedCrossRefGoogle Scholar
  232. Wiklund PG, Nilsson L, Ardnor SN, Eriksson P, Johansson L, Stegmayr B, Hamsten A, Holmberg D, Asplund K (2005) Plasminogen activator inhibitor-1 4G/5G polymorphism and risk of stroke: replicated findings in two nested case–control studies based on independent cohorts. Stroke 36(8):1661–1665PubMedCrossRefGoogle Scholar
  233. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311:501–505PubMedCrossRefGoogle Scholar
  234. Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 40(2):161–169PubMedCrossRefGoogle Scholar
  235. Wilson CP, McNulty H, Scott JM, Strain JJ, Ward M (2011) Postgraduate Symposium: The MTHFR C677T polymorphism, B-vitamins and blood pressure. Proc Nutr Soc 69(1):156–165CrossRefGoogle Scholar
  236. Wu AH, Tsongalis GJ (2001) Correlation of polymorphisms to coagulation and biochemical risk factors for cardiovascular diseases. Am J Cardiol 87:1361–1366PubMedCrossRefGoogle Scholar
  237. Xu Y, Tuteja D, Zhang Z, Xu D, Zhang Y, Rodriguez J, Nie L, Tuxson HR, Young JN, Glatter KA, Vazquez AE, Yamoah EN, Chiamvimonvat N (2003) Molecular identification and functional roles of a Ca(2+)-activated K  +  channel in human and mouse hearts. J Biol Chem 278:49085–49094PubMedCrossRefGoogle Scholar
  238. Xin XY, Song YY, Ma JF, Fan CN, Ding JQ, Yang GY, Chen SD (2009) Gene polymorphisms and risk of adult early-onset ischemic stroke: A meta-analysis. Thromb Res 124(5):619–624PubMedCrossRefGoogle Scholar
  239. Yang Q, Kathiresan S, Lin JP, Tofler GH, O’Donnell CJ (2007a) Genome-wide association and linkage analyses of hemostatic factors and hematological phenotypes in the Framingham Heart Study. BMC Med Genet 8(Suppl 1):S12PubMedCrossRefGoogle Scholar
  240. Yang WS, Yang YC, Chen CL, Wu IL, Lu JY, Lu FH, Tai TY, Chang CJ (2007b) Adiponectin SNP276 is associated with obesity, the metabolic syndrome, and diabetes in the elderly. Am J Clin Nutr 86(2):509–513PubMedGoogle Scholar
  241. Ye Z, Liu EH, Higgins JP, Keavney BD, Lowe GD, Collins R, Danesh J (2006) Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls. Lancet 367(9511):651–658PubMedCrossRefGoogle Scholar
  242. Young EH, Wareham NJ, Farooqi S, Hinney A, Hebebrand J, Scherag A, O’rahilly S, Barroso I, Sandhu MS (2007) The V103I polymorphism of the MC4R gene and obesity: population based studies and meta-analysis of 29 563 individuals. Int J Obes (Lond) 31(9):1437–1441CrossRefGoogle Scholar
  243. Zee RY, Glynn RJ, Cheng S, Steiner L, Rose L, Ridker PM (2009) An evaluation of candidate genes of inflammation and thrombosis in relation to the risk of venous thromboembolism: The Women’s Genome Health Study. Circ Cardiovasc Genet 2(1):57–62PubMedCrossRefGoogle Scholar
  244. Zhang H, Wu LM, Wu J (2011) Cross-talk between apolipoprotein E and cytokines. Mediators Inflamm 2011:949072PubMedGoogle Scholar
  245. Zhang X, Lynch AI, Davis BR, Ford CE, Boerwinkle E, Eckfeldt JH, Leiendecker-Foster C, Arnett DK (2012) Pharmacogenetic association of NOS3 variants with cardiovascular disease in patients with hypertension: the GenHAT study. PLoS One 7(3):e34217PubMedCrossRefGoogle Scholar
  246. Zhao YH, Xu Y, Gu YY, Li Y, Zhang JY, Su X (2011) Functional effect of platelet membrane glycoprotein Ia gene polymorphism in the pathogenesis of unstable angina pectoris. J Int Med Res 39(2):541–548PubMedCrossRefGoogle Scholar
  247. Ziemke F, Mantzoros CS (2010) Adiponectin in insulin resistance: lessons from translational research. Am J Clin Nutr 91(suppl):258S–261SPubMedCrossRefGoogle Scholar
  248. Zito F, Drummond F, Bujac SR, Esnouf MP, Morrissey JH, Humphries SE, Miller GJ (2000) Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation 102:2058–2062PubMedCrossRefGoogle Scholar
  249. Zipes DP, Wellens HJ (1998) Sudden cardiac death. Circulation 98(21):2334–2351PubMedCrossRefGoogle Scholar
  250. Zobel DP, Andreasen CH, Burgdorf KS, Andersson EA, Sandbaek A, Lauritzen T, Borch-Johnsen K, Jørgensen T, Maeda S, Nakamura Y, Eiberg H, Pedersen O, Hansen T (2009) Variation in the gene encoding Krüppel-like factor 7 influences body fat: studies of 14 818 Danes. Eur J Endocrinol 160(4):603–609PubMedCrossRefGoogle Scholar
  251. Zorio E, Gilabert-Estellés J, España F, Ramón LA, Cosín R, Estellés A (2008) Fibrinolysis: the key to new pathogenetic mechanisms. Curr Med Chem 15(9):923–929PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • Christine Mannhalter
    • 1
    Email author
  • Michael Poteser
    • 2
  • Klaus Groschner
    • 2
  1. 1.Department of Laboratory MedicineMedical University of ViennaViennaAustria
  2. 2.Center for Physiological Medicine, Institute of BiophysicsMedical University of GrazGrazAustria

Personalised recommendations